BCMA chimeric antigen receptors and uses thereof
AU2026205442A1Pending Publication Date: 2026-08-06NOVARTIS AG
View PDF 0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- NOVARTIS AG
- Filing Date
- 2026-07-08
- Publication Date
- 2026-08-06
Smart Images
Figure 00000226_0000 
Figure 00000226_0001 
Figure 00000227_0000
Abstract
The invention provides compositions and methods for treating diseases associated with expression of BCMA. The invention also relates to chimeric antigen receptor (CAR) specific to BCMA, vectors encoding the same, and recombinant T cells comprising the BCMA CAR. The invention also includes methods of administering a genetically modified T cell expressing a CAR that comprises a BCMA binding domain. 20 26 20 54 42 08 J ul 2 02 6 A B S T R A C T 2 0 2 6 2 0 5 4 4 2 0 8 J u l 2 0 2 6
Need to check novelty before this filing date? Find Prior Art